Cargando…

Treatment of Tumors with Vitamin E Suppresses Myeloid Derived Suppressor Cells and Enhances CD8+ T Cell-Mediated Antitumor Effects

Vitamin E has been shown to have strong anticarcinogenic properties, including antioxidant characteristics, making it an ideal candidate for use in combination with immunotherapies that modify the tumor microenvironment. The tumor microenvironment contains immunosuppressive components, which can be...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kang, Tae Heung, Knoff, Jayne, Yeh, Wei-Hsi, Yang, Benjamin, Wang, Chenguang, Kim, Young Seob, Kim, Tae Woo, Wu, Tzyy-Choou, Hung, Chien-Fu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4114790/ https://www.ncbi.nlm.nih.gov/pubmed/25072795 http://dx.doi.org/10.1371/journal.pone.0103562

Ejemplares similares

Combination of proteasome and HDAC inhibitor enhances HPV16 E7-specific CD8(+) T cell immune response and antitumor effects in a preclinical cervical cancer model
por: Huang, Zhuomin, et al.
Publicado: (2015)

Depletion of platelets enhances therapeutic antitumor effects generated by therapeutic DNA vaccine
por: Lee, Sung Yong, et al.
Publicado: (2013)

Antitumor Efficacy of EGFR-Targeted Recombinant Immunotoxin in Human Head and Neck Squamous Cell Carcinoma
por: Xie, Guiqin, et al.
Publicado: (2022)

Control of spontaneous ovarian tumors by CD8+ T cells through NKG2D-targeted delivery of antigenic peptide
por: Kang, Tae Heung, et al.
Publicado: (2013)

Understanding the Differentiation, Expansion, Recruitment and Suppressive Activities of Myeloid-Derived Suppressor Cells in Cancers
por: Lim, Hui Xuan, et al.
Publicado: (2020)

Myeloid Suppressor Cell Depletion Augments Antitumor Activity in Lung Cancer
por: Srivastava, Minu K., et al.
Publicado: (2012)

Correction: Myeloid Suppressor Cell Depletion Augments Antitumor Activity in Lung Cancer
por: Srivastava, Minu K., et al.
Publicado: (2012)

CD205(+) polymorphonuclear myeloid‐derived suppressor cells suppress antitumor immunity by overexpressing GLUT3
por: Fu, Chenghao, et al.
Publicado: (2021)

NAMPT-targeting PROTAC promotes antitumor immunity via suppressing myeloid-derived suppressor cell expansion
por: Wu, Ying, et al.
Publicado: (2022)

Targeting myeloid-derived suppressor cells augments antitumor activity against lung cancer
por: Srivastava, Minu K, et al.
Publicado: (2012)

Myeloid-Derived Suppressor Cells Specifically Suppress IFN-γ Production and Antitumor Cytotoxic Activity of Vδ2 T Cells
por: Sacchi, Alessandra, et al.
Publicado: (2018)

Cancer Immunotherapy Employing an Innovative Strategy to Enhance CD4+ T Cell Help in the Tumor Microenvironment
por: Song, Liwen, et al.
Publicado: (2014)

Targeting Myeloid-Derived Suppressor Cells to Enhance the Antitumor Efficacy of Immune Checkpoint Blockade Therapy
por: Li, Xueyan, et al.
Publicado: (2021)

Taurodeoxycholate Increases the Number of Myeloid-Derived Suppressor Cells That Ameliorate Sepsis in Mice
por: Chang, Sooghee, et al.
Publicado: (2018)

Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell function
por: Serafini, Paolo, et al.
Publicado: (2006)

Antitumor effects of targeting myeloid-derived suppressive cells
por: Zeng, Dong, et al.
Publicado: (2020)

Different role of circulating myeloid-derived suppressor cells in patients with multiple myeloma undergoing autologous stem cell transplantation
por: Lee, Sung-Eun, et al.
Publicado: (2019)

Myeloid-Derived Suppressor Cells in Inflammatory Bowel Disease
por: Kim, Yeon-Jeong, et al.
Publicado: (2015)

Myeloid Derived Suppressor Cells in Chronic Myeloid Leukemia
por: Giallongo, Cesarina, et al.
Publicado: (2015)

Myeloid-Derived Suppressor Cells in Sepsis
por: Lai, Dengming, et al.
Publicado: (2014)

Myeloid-Derived Suppressor Cells in Sepsis
por: Schrijver, Irene T., et al.
Publicado: (2019)

On the origin of myeloid-derived suppressor cells
por: Millrud, Camilla Rydberg, et al.
Publicado: (2016)

Myeloid-derived suppressor cells in gliomas
por: Gieryng, Anna, et al.
Publicado: (2016)

Pancreatic adenocarcinoma up-regulated factor (PAUF) enhances the accumulation and functional activity of myeloid-derived suppressor cells (MDSCs) in pancreatic cancer
por: Song, Jinhoi, et al.
Publicado: (2016)

Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity
por: Veglia, Filippo, et al.
Publicado: (2021)

Activated T cells sustain myeloid-derived suppressor cell-mediated immune suppression
por: Pinton, Laura, et al.
Publicado: (2015)

Targeting TREM1 augments antitumor T cell immunity by inhibiting myeloid-derived suppressor cells and restraining anti–PD-1 resistance
por: Ajith, Ashwin, et al.
Publicado: (2023)

Immune Modulation by Myeloid-Derived Suppressor Cells in Diabetic Kidney Disease
por: Hsieh, Ching-Chuan, et al.
Publicado: (2022)

RPN13/ADRM1 inhibitor reverses immunosuppression by myeloid-derived suppressor cells
por: Soong, Ruey-Shyang, et al.
Publicado: (2016)

Endoplasmic reticulum stress enhances the antigen-specific T cell immune responses and therapeutic antitumor effects generated by therapeutic HPV vaccines
por: Lee, Sung Yong, et al.
Publicado: (2019)

Myeloid-Derived Suppressor Cells and Mesenchymal Stem/Stromal Cells in Myeloid Malignancies
por: Kapor, Suncica, et al.
Publicado: (2021)

Tumor-Suppressive Effect of Metformin via the Regulation of M2 Macrophages and Myeloid-Derived Suppressor Cells in the Tumor Microenvironment of Colorectal Cancer
por: Kang, Joyeon, et al.
Publicado: (2022)

Recombinant immunotoxin induces tumor intrinsic STING signaling against head and neck squamous cell carcinoma
por: Xie, Guiqin, et al.
Publicado: (2023)

3,3′-Diindolylmethane improves antitumor immune responses of PD-1 blockade via inhibiting myeloid-derived suppressor cells
por: Sun, Qi, et al.
Publicado: (2022)

Myeloid derived suppressor cells: Targets for therapy
por: Waldron, Todd J., et al.
Publicado: (2013)

Myeloid-derived suppressor cells, age and cancer
por: Bowdish, Dawn ME
Publicado: (2013)

Chemotherapeutic targeting of myeloid-derived suppressor cells
por: Alizadeh, Darya, et al.
Publicado: (2014)

Myeloid Derived Suppressor Cells: Fuel the Fire
por: Achyut, B. R., et al.
Publicado: (2014)

Myeloid-Derived Suppressor Cells in Bacterial Infections
por: Ost, Michael, et al.
Publicado: (2016)

Myeloid-Derived Suppressor Cells and Pulmonary Hypertension
por: Bryant, Andrew J., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ajvufp5n39037r4p0cet7dan01